As of 2026-09-14, the EV/EBITDA ratio of Proteome Sciences PLC (PRM.L) is -11.88. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRM.L's latest enterprise value is 20.68 mil GBP. PRM.L's TTM EBITDA according to its financial statements is -1.74 mil GBP. Dividing these 2 quantities gives us the above PRM.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 23.4x | 16.5x |
| Forward P/E multiples | 11.2x - 15.2x | 12.6x |
| Fair Price | (8.47) - (10.21) | (9.92) |
| Upside | -705.1% - -829.3% | -808.8% |
| Date | EV/EBITDA |
| 2026-09-11 | -12.04 |
| 2026-09-10 | -11.90 |
| 2026-09-09 | -11.92 |
| 2026-09-08 | -11.95 |
| 2026-09-07 | -11.97 |
| 2026-09-04 | -12.04 |
| 2026-09-03 | -12.02 |
| 2026-09-02 | -11.92 |
| 2026-09-01 | -11.96 |
| 2026-08-28 | -12.39 |
| 2026-08-27 | -12.00 |
| 2026-08-26 | -12.34 |
| 2026-08-25 | -12.38 |
| 2026-08-24 | -12.32 |
| 2026-08-21 | -12.50 |
| 2026-08-20 | -12.60 |
| 2026-08-19 | -12.85 |
| 2026-08-18 | -12.88 |
| 2026-08-17 | -12.89 |
| 2026-08-14 | -12.99 |
| 2026-08-13 | -12.83 |
| 2026-08-12 | -12.86 |
| 2026-08-11 | -12.82 |
| 2026-08-10 | -12.92 |
| 2026-08-07 | -13.28 |
| 2026-08-06 | -12.83 |
| 2026-08-05 | -12.86 |
| 2026-08-04 | -12.88 |
| 2026-08-03 | -12.90 |
| 2026-07-31 | -12.97 |
| 2026-07-30 | -12.83 |
| 2026-07-29 | -12.86 |
| 2026-07-28 | -12.88 |
| 2026-07-27 | -13.14 |
| 2026-07-22 | -12.37 |
| 2026-07-17 | -12.14 |
| 2026-07-15 | -13.32 |
| 2026-07-13 | -13.25 |
| 2026-07-10 | -12.74 |
| 2026-07-09 | -12.61 |
| 2026-07-08 | -12.37 |
| 2026-07-07 | -11.91 |
| 2026-07-06 | -12.55 |
| 2026-07-03 | -11.67 |
| 2026-07-02 | -12.48 |
| 2026-07-01 | -12.51 |
| 2026-06-30 | -13.28 |
| 2026-06-29 | -12.90 |
| 2026-06-26 | -12.14 |
| 2026-06-25 | -12.58 |